Bio-Rad Laboratories Inc (BIO)
Activity ratios
Short-term
Turnover ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inventory turnover | 1.56 | 1.46 | 1.47 | 1.55 | 1.59 | 1.63 | 1.64 | 1.66 | 1.71 | 1.79 | 1.88 | 2.07 | 2.24 | 2.17 | 2.09 | 1.95 | 1.78 | 1.67 | 1.66 | 1.92 |
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Working capital turnover | 1.00 | 1.01 | 1.00 | 1.00 | 1.06 | 1.05 | 1.08 | 1.03 | 1.08 | 1.09 | 1.09 | 1.09 | 2.23 | 1.64 | 1.69 | 1.73 | 1.69 | 1.78 | 1.90 | 1.92 |
Bio-Rad Laboratories Inc's inventory turnover has shown fluctuations over the years. It started at 1.92 in March 2020, decreased to 1.47 in June 2024, and then slightly increased to 1.56 by December 2024. Generally, the downward trend indicates that the company may be holding onto inventory for longer periods, which could tie up working capital and impact profitability.
The information for receivables turnover and payables turnover is not available, indicating that data on how efficiently the company is collecting receivables and paying its suppliers is missing. This lack of data limits the ability to assess the effectiveness of the company's credit and payment policies.
The working capital turnover ratio provides insight into how effectively the company utilizes its working capital to generate sales revenue. The ratio fluctuated over the years, ranging from 1.00 to 2.23. A higher ratio suggests better efficiency in utilizing working capital to generate sales, while a lower ratio may indicate inefficiencies in working capital management.
In conclusion, the inventory turnover and working capital turnover ratios provide some insights into Bio-Rad Laboratories Inc's efficiency in managing inventory and working capital. However, the lack of data on receivables turnover and payables turnover limits a comprehensive analysis of the company's overall activity ratios.
Average number of days
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | 233.81 | 249.58 | 248.85 | 235.39 | 228.87 | 224.26 | 222.63 | 219.90 | 213.14 | 203.46 | 194.53 | 176.49 | 162.94 | 167.96 | 174.89 | 187.24 | 205.02 | 217.97 | 219.33 | 190.60 |
| Days of sales outstanding (DSO) | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Number of days of payables | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Bio-Rad Laboratories Inc's days of inventory on hand (DOH) has been fluctuating over the years. It increased from 190.60 days as of March 31, 2020, to 248.85 days as of June 30, 2024, with some variations in between. This indicates that the company held inventory for a longer period as of June 30, 2024, compared to March 31, 2020.
Unfortunately, the data for days of sales outstanding (DSO) and number of days of payables is unavailable, making it challenging to assess the efficiency of the company in collecting receivables and managing payables.
Overall, a high DOH may suggest inventory management issues, such as overstocking or slow-moving inventory, which could tie up capital. It is advisable for Bio-Rad Laboratories Inc to analyze the reasons behind the fluctuations in DOH to optimize inventory levels and improve operational efficiency.
Long-term
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fixed asset turnover | — | — | — | — | — | 3.82 | 4.03 | 4.08 | 5.62 | 4.43 | 4.37 | 4.23 | 4.20 | 4.38 | 4.28 | 3.98 | 5.18 | 3.51 | 3.38 | 4.79 |
| Total asset turnover | 0.27 | 0.24 | 0.26 | 0.21 | 0.22 | 0.23 | 0.23 | 0.20 | 0.21 | 0.23 | 0.23 | 0.20 | 0.16 | 0.15 | 0.19 | 0.19 | 0.20 | 0.20 | 0.23 | 0.27 |
The fixed asset turnover ratio for Bio-Rad Laboratories Inc has shown fluctuations over the years, ranging from 3.38 to 5.62. This ratio indicates the company's ability to generate sales from its fixed assets, with higher values suggesting better efficiency in utilizing fixed assets to generate revenue.
On the other hand, the total asset turnover ratio has been relatively low, fluctuating between 0.15 and 0.27. This metric reflects Bio-Rad Laboratories Inc's ability to generate sales from all its assets, both fixed and current. A lower total asset turnover ratio suggests that the company may not be effectively utilizing its assets to generate revenue.
Overall, while the fixed asset turnover ratio indicates relatively efficient use of fixed assets, the total asset turnover ratio suggests room for improvement in leveraging all assets to drive sales for Bio-Rad Laboratories Inc.